PHARMACOKINETIC INTERACTION STUDY WITH RAMIPRIL AND DIGOXIN IN HEALTHY-VOLUNTEERS

被引：20

作者：

DOERING, W

MAASS, L

IRMISCH, R

KONIG, E

机构：

[1] AKAD LEHRKRANKENHAUS MUNCHEN SCHWABING,DIV CARDIOL,MUNICH,FED REP GER

[2] HOECHST AG,CLIN PHARMACOL,D-6230 FRANKFURT 80,FED REP GER

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1987年 / 59卷 / 10期

关键词：

D O I：

10.1016/0002-9149(87)90055-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：D60 / D64

页数：5

共 7 条

[1]

CLELAND JGF, 1984, BRIT J CLIN PHARMACO, V17, pP214

[2] ACUTE REGIONAL CIRCULATORY AND RENAL HEMODYNAMIC-EFFECTS OF CONVERTING-ENZYME INHIBITION IN PATIENTS WITH CONGESTIVE HEART-FAILURE [J].

CREAGER, MA ;

HALPERIN, JL ;

BERNARD, DB ;

FAXON, DP ;

MELIDOSSIAN, CD ;

GAVRAS, H ;

RYAN, TJ .

CIRCULATION, 1981, 64 (03) :483-489

[3] QUINIDINE-DIGOXIN INTERACTION - PHARMACOKINETICS, UNDERLYING MECHANISM AND CLINICAL IMPLICATIONS [J].

DOERING, W .

NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (08) :400-404

[4]

ECKERT HG, 1985, DRUG RES, V35, P1251

[5] THE QUINIDINE-DIGOXIN INTERACTION IN PERSPECTIVE [J].

FICHTL, B ;

DOERING, W .

CLINICAL PHARMACOKINETICS, 1983, 8 (02) :137-154

[6]

STUMPE KO, 1984, THERAPIEWOCHE, V34, P3290

[7] PHARMACOKINETICS AND PHARMACODYNAMICS OF A NOVEL ORALLY ACTIVE ANGIOTENSIN CONVERTING ENZYME-INHIBITOR (HOE 498) IN HEALTHY-SUBJECTS [J].

WITTE, PU ;

IRMISCH, R ;

HAJDU, P ;

METZGER, H .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 27 (05) :577-581

← 1 →